ArticleAnnals of hematology2021

High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells.

Zhihong Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.